Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Randomised clinical trial: the effectiveness of Lactobacillus reuteri ATCC 55730 rectal enema in children with active distal ulcerative colitis
Salvatore Oliva, Giovanni Di Nardo, Federica Ferrari, et al.
Alimentary Pharmacology & Therapeutics (2011) Vol. 35, Iss. 3, pp. 327-334
Open Access | Times Cited: 257

Showing 1-25 of 257 citing articles:

Intestinal permeability – a new target for disease prevention and therapy
Stephan C. Bischoff, Giovanni Barbara, Wim A. Buurman, et al.
BMC Gastroenterology (2014) Vol. 14, Iss. 1
Open Access | Times Cited: 1497
Alteration of Gut Microbiota in Inflammatory Bowel Disease (IBD): Cause or Consequence? IBD Treatment Targeting the Gut Microbiome
Israr Khan, Naeem Ullah, Lajia Zha, et al.
Pathogens (2019) Vol. 8, Iss. 3, pp. 126-126
Open Access | Times Cited: 643
Anti-Inflammatory and Immunomodulatory Effects of Probiotics in Gut Inflammation: A Door to the Body
Fernanda Cristofori, Vanessa Nadia Dargenio, Costantino Dargenio, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 561
ESPEN guideline: Clinical nutrition in inflammatory bowel disease
Alastair Forbes, Johanna C. Escher, Xavier Hébuterne, et al.
Clinical Nutrition (2017) Vol. 36, Iss. 2, pp. 321-347
Open Access | Times Cited: 545
Hyaluronic acid–bilirubin nanomedicine for targeted modulation of dysregulated intestinal barrier, microbiome and immune responses in colitis
Yonghyun Lee, Kohei Sugihara, Merritt Gillilland, et al.
Nature Materials (2019) Vol. 19, Iss. 1, pp. 118-126
Open Access | Times Cited: 542
Relationship between intestinal microbiota and ulcerative colitis: Mechanisms and clinical application of probiotics and fecal microbiota transplantation
Zhaohua Shen, Changxin Zhu, Yongsheng Quan, et al.
World Journal of Gastroenterology (2018) Vol. 24, Iss. 1, pp. 5-14
Open Access | Times Cited: 541
Bifidobacterium infantis35624 modulates host inflammatory processes beyond the gut
David Groeger, Liam O’Mahony, Eileen F. Murphy, et al.
Gut Microbes (2013) Vol. 4, Iss. 4, pp. 325-339
Open Access | Times Cited: 403
Management of Paediatric Ulcerative Colitis, Part 1
Dan Turner, Frank M. Ruemmele, E Orlanski-Meyer, et al.
Journal of Pediatric Gastroenterology and Nutrition (2018) Vol. 67, Iss. 2, pp. 257-291
Open Access | Times Cited: 372
Management of Pediatric Ulcerative Colitis
Dan Turner, Arie Levine, Johanna C. Escher, et al.
Journal of Pediatric Gastroenterology and Nutrition (2012) Vol. 55, Iss. 3, pp. 340-361
Open Access | Times Cited: 357
The Role of Probiotic Lactic Acid Bacteria and Bifidobacteria in the Prevention and Treatment of Inflammatory Bowel Disease and Other Related Diseases: A Systematic Review of Randomized Human Clinical Trials
María José Sáez‐Lara, Carolina Gómez‐Llorente, Julio Plaza‐Díaz, et al.
BioMed Research International (2015) Vol. 2015, pp. 1-15
Open Access | Times Cited: 353
Probiotics are a good choice in remission of inflammatory bowel diseases: A meta analysis and systematic review
Mahboube Ganji‐Arjenaki, Mahmoud Rafieian‐Kopaei
Journal of Cellular Physiology (2017) Vol. 233, Iss. 3, pp. 2091-2103
Closed Access | Times Cited: 294
Interactions between Intestinal Microbiota and Host Immune Response in Inflammatory Bowel Disease
Ming Zhang, Kaiji Sun, Yujun Wu, et al.
Frontiers in Immunology (2017) Vol. 8
Open Access | Times Cited: 292
Systematic review of randomized controlled trials of probiotics, prebiotics, and synbiotics in inflammatory bowel disease
Andrew Dupont, Richards, Katherine Jelinek, et al.
Clinical and Experimental Gastroenterology (2014), pp. 473-473
Open Access | Times Cited: 290
ESPEN practical guideline: Clinical Nutrition in inflammatory bowel disease
Stephan C. Bischoff, Johanna C. Escher, Xavier Hébuterne, et al.
Clinical Nutrition (2020) Vol. 39, Iss. 3, pp. 632-653
Closed Access | Times Cited: 287
Effectiveness of probiotics, prebiotics, and prebiotic‐like components in common functional foods
Mengfei Peng, Zajeba Tabashsum, Mary Anderson, et al.
Comprehensive Reviews in Food Science and Food Safety (2020) Vol. 19, Iss. 4, pp. 1908-1933
Closed Access | Times Cited: 200
The microbiome in inflammatory bowel diseases: from pathogenesis to therapy
Sheng Liu, Wenjing Zhao, Ping Lan, et al.
Protein & Cell (2020) Vol. 12, Iss. 5, pp. 331-345
Open Access | Times Cited: 199
Reuterin in the healthy gut microbiome suppresses colorectal cancer growth through altering redox balance
Hannah N. Bell, Ryan Rebernick, Joshua Goyert, et al.
Cancer Cell (2021) Vol. 40, Iss. 2, pp. 185-200.e6
Open Access | Times Cited: 191
Probiotics for prevention and treatment of respiratory tract infections in children
Yizhong Wang, Xiaolu Li, Ting Ge, et al.
Medicine (2016) Vol. 95, Iss. 31, pp. e4509-e4509
Open Access | Times Cited: 184
Probiotics in Inflammatory Bowel Disease
Bincy Abraham, Eamonn M.M. Quigley
Gastroenterology Clinics of North America (2017) Vol. 46, Iss. 4, pp. 769-782
Closed Access | Times Cited: 179
Role of probiotics to combat viral infections with emphasis on COVID-19
Aravind Sundararaman, Mousumi Ray, Ravindra P. Veeranna, et al.
Applied Microbiology and Biotechnology (2020) Vol. 104, Iss. 19, pp. 8089-8104
Open Access | Times Cited: 171
Microbial-Based and Microbial-Targeted Therapies for Inflammatory Bowel Diseases
Akihiko Oka, R. Balfour Sartor
Digestive Diseases and Sciences (2020) Vol. 65, Iss. 3, pp. 757-788
Open Access | Times Cited: 145
Bile Acid–Gut Microbiota Axis in Inflammatory Bowel Disease: From Bench to Bedside
Min Yang, Yu Gu, Lingfeng Li, et al.
Nutrients (2021) Vol. 13, Iss. 9, pp. 3143-3143
Open Access | Times Cited: 127
Probiotics for the Management of Pediatric Gastrointestinal Disorders: Position Paper of the ESPGHAN Special Interest Group on Gut Microbiota and Modifications
Hania Szajewska, Roberto Berni Canani, Magnus Domellöf, et al.
Journal of Pediatric Gastroenterology and Nutrition (2022) Vol. 76, Iss. 2, pp. 232-247
Open Access | Times Cited: 100
Microbiota-derived tryptophan catabolites mediate the chemopreventive effects of statins on colorectal cancer
Ji‐Xuan Han, Zhi‐Hang Tao, Jilin Wang, et al.
Nature Microbiology (2023) Vol. 8, Iss. 5, pp. 919-933
Open Access | Times Cited: 96
The role of Th17 cells in inflammatory bowel disease and the research progress
Lu Chen, Guangcong Ruan, Yi Cheng, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 87
Page 1 - Next Page

Scroll to top